TRAVERE THERAPEUTICS, INC. Derivative, Gain (Loss) on Derivative, Net
TRAVERE THERAPEUTICS, INC. (TVTX) reported Derivative, Gain (Loss) on Derivative, Net of -$32.98 million for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2015-07-09
- TRAVERE THERAPEUTICS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2014-06-30 was -$32.98M.
- TRAVERE THERAPEUTICS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2014-03-31 was $53.61M, a 1722.15% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2013-12-31 was -$1.18M.
- TRAVERE THERAPEUTICS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2013-09-30 was -$6.04M.
- TRAVERE THERAPEUTICS, INC. derivative, gain (loss) on derivative, net for fiscal 2013 was -$10.10M.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 3 month as first filed | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 9 month as first filed | Derivative, Gain (Loss) on Derivative, Net 12 month | Derivative, Gain (Loss) on Derivative, Net 12 month as first filed | Derivative, Gain (Loss) on Derivative, Net 25 month | Derivative, Gain (Loss) on Derivative, Net 28 month | Derivative, Gain (Loss) on Derivative, Net 31 month | Derivative, Gain (Loss) on Derivative, Net 31 month as first filed | Derivative, Gain (Loss) on Derivative, Net 34 month | Derivative, Gain (Loss) on Derivative, Net 34 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | -$32.98M 10-Q · filed 2014-08-14 | $20.64M 10-Q · filed 2014-08-14 | $19.45M derived: sum of 3 quarters · filed 2015-07-09 | $13.41M derived: sum of 4 quarters · filed 2015-07-09 | |||||||||
| 2014-03-31 | $53.61M 10-Q · filed 2014-05-15 | $52.43M derived: sum of 2 quarters · filed 2015-07-09 | $46.39M derived: sum of 3 quarters · filed 2015-07-09 | $46.33M derived: sum of 4 quarters · filed 2015-07-09 | |||||||||
| 2013-12-31 | -$1.18M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2015-07-09 | -$7.22M derived: sum of 2 quarters · filed 2015-07-09 | -$7.28M derived: sum of 3 quarters · filed 2015-07-09 | -$10.10M 10-K/A · filed 2015-07-09 | $10.10M 10-K · filed 2014-03-28 | -$10.10M 10-K/A · filed 2015-07-09 | $10.10M 10-K · filed 2014-03-28 | ||||||
| 2013-09-30 | -$6.04M 10-Q/A · filed 2015-07-09 | $5.80M 10-Q · filed 2013-11-13 | -$6.10M derived: sum of 2 quarters · filed 2015-07-09 | -$8.92M 10-Q/A · filed 2015-07-09 | $8.20M 10-Q · filed 2013-11-13 | -$8.92M 10-Q/A · filed 2015-07-09 | $8.20M 10-Q · filed 2013-11-13 | ||||||
| 2013-06-30 | -$56.04K 10-Q · filed 2014-08-14 | $2.40M 10-Q · filed 2014-08-14 | $2.40M 10-Q · filed 2013-09-16 | ||||||||||
| 2013-03-31 | $2.94M 10-Q · filed 2014-05-15 | $2.45M 10-Q · filed 2013-07-24 | $2.45M 10-Q/A · filed 2013-09-16 | ||||||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 | |||||||||||
| 2012-03-31 | $0.00 10-Q/A · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |